derived from methionine and of glutamyl hydrazine, though both antagonized by glutamine, are biochemically distinct. Localization of the point of action of an analogue, as illustrated in figure 1, is thus an essential preliminary to any inter pretation of their potencies in electromeric terms.
Se l e c t iv e t o x ic it y , an e s s e n t ia l r e q u ir e m e n t fo r SUCCESSFUL CHEMOTHERAPY B y T. S. W o r k Chemotherapeutic research is judged, ultimately, by its ability to produce new and successful drugs for the treatm ent of disease. Success may be fortuitous or it may be the result of an inspired guess into the future. I t is my task to-day to examine current theories on metabolite analogues and to assess their value as a pointer towards further progress.
A glance at past progress may help us to assess more fairly the present position. Table 4 gives a short list of notable chemotherapeutic drugs together with their origin and date of introduction into European medicine. It is apparent from this table th at shortly before 1900 prevailing ideas must have undergone some fundamental change which resulted in a sudden blossoming of the whole subject. The new idea was the germ theory of disease, and its direct offshoot was the subculture of pathogenic organisms both in vitro and vivo. Despite the accumulation of information for over forty years there has been no marked acceleration of the rate of progress, and the production of a new and successful drug is still a long and difficult problem. Indeed, so much is this true, that a prominent research worker in the field recently remarked th at he knew only two methods for the production of new drugs-'the hit-and-miss method, where the starting point was a compound of known activity upon which the organic chemist played variations, and the miss-and-miss method, where the starting point was any old chemical from the store cupboard With this criticism in mind, I should like to review some of the theoretical and practical achievements of recent years.
The first general theory of chemotherapy, Ehrlich's receptor theory, did much to stimulate the early stages of chemotherapeutic research, but rather surprisingly failed to associate receptors with enzymes. The idea was not wholly ignored, how ever, as Simon & Wood (1914) remarked, 'since intracellular metabolism is inti mately connected with the action of enzymes the question has naturally suggested itself whether the deleterious action of dyes may not in part be referable to inter ference with the activity of these components'. Over a period of years, the idea th at drugs act through enzyme inhibition gained gradual acceptance and finally crystallized in one form as the Eildes-Woods hypothesis, upon which I need not expand. I must, however, draw attention to the comparative failure of research based on the production of metabolite analogues to provide any significant new advance in practical chemotherapy.
Those outstanding anti-metabolites, the sulphonamides, were discovered before the recognition of the metabolic importance of p-aminobenzoic acid and must be credited to the account of the old hit-and-miss method. The thiamin analogue pyrithiamin inhibits certain bacteria, but is useless as a chemotherapeutic remedy because it causes thiamin deficiency in the host (Woolley & White 1943) . The panto thenic acid analogue, pantoyltaurine, shows slight chemotherapeutic activity, but is over-rapidly excreted and also inactivated by pantothenic acid of the host tissue (Mcllwain & Hawking 1943) . One minor success of the anti-metabolite approach is the treatm ent of malaria by phenylpantothenone and other pantothenic acid analogues (Woolley & Collyer 1945; Brackett, Waletzky & Baker 1946; Senear, Rapport & Koepfli 1947 ). This comparative failure should be contrasted with the success of the more orthodox approach to chemotherapy which has provided in the same period, 1940 to 1948, such drugs as penicillin and paludrine, to mention only two out of many.
Should we, then, abandon the anti-metabolite approach as philosophically attrac tive but useless in practical chemotherapy ? To do so would surely be to display excessive impatience. In the brief period of eight years since its inception this approach has, as already mentioned, produced one series of drugs active in clinical malaria. But for quinine and the armament of synthetic anti-malarials collected during more than forty years of intensive research, these compounds would have been hailed as a considerable triumph for the anti-metabolite theory. Perhaps it is not so much the theory which is at fault, but rather that we expect too much of it and know too little to apply it. Our theoretical approach to the synthesis of new drugs may require modification, our knowledge of cellular metabolism certainly requires expansion.
Study of the mode of action of certain successful chemotherapeutic drugs suggest s one direction in which the anti-metabolite approach might be advantageously modified. As long ago as 1909, Ehrlich suggested that arsenicals might be toxic because of their affinity for thiol groups. He and his contemporaries proceeded to develop one of the most successful groups of drugs, the organic arsenicals, but they failed to suggest any reason why these drugs destroyed the pathogen rather than the host. This difficulty was clearly recognized by Voegtlin (1925) , who remarks, in his discussion: 'we agree with this explanation as far as it goes, but it still has to be explained why the host tissues can resist the toxic action of a slow stream of arsenoxide better than the parasites.' At another point in the same paper Yoegtlin says: ' a vast amount of work on the biochemistry of both host tissues and especially of the parasites is required to settle this point and new experimental methods must be devised for the solution of this fundamental problem.' Voegtlin's plea has not gone unanswered; with the growth of enzymology and parasitology new experimental methods have been devised, and the results obtained do suggest an explanation for the selective toxicity of arsenicals.
In 1929 Yorke, Adams & Murgatroyd developed a medium for the maintenance of pathogenic trypanosomes and showed th at Trypanosoma rhodesiense consumed more than twice its own weight of glucose in 24 hr. The presence of glucose was essential for the life of the trypanosome; glucose consumption and respiration were extinguished simultaneously by trypanocidal arsenoxides. The inference drawn from these observations was th at trypanocidal drugs acted by inhibiting glucose metabolism.
The nature of glucose metabolism in trypanosomes has been indicated by various observations extending over a number of years. Reiner & Smythe (1934) showed that T. equiperdum produced pyruvic acid from glucose; Fulton & Stevens (1945) found pyruvic acid, lactic acid, acetic acid, formic acid, succinic acid, glycerol and ethanol as products of metabolism in T. th at lysed trypanosomes converted glucose to fructose-1:6-diphosphate, and this to 3-phosphoglyceraldehyde and to phosphoglyceric acid. Glucose metabolism of T. rhodesiense was not inhibited by cyanide (Christophers & Fulton 1938) . All these results taken together suggest th at in some strains of pathogenic trypanosome glucose metabolism follows the anaerobic glycolytic pathway mapped out for muscle and for yeast fermentation. Certain enzymes of this system have been shown to be SH-enzymes and are readily inhibited by extremely low concentrations of SH-reagents such as iodoacetamide, lewisite and the various arsenoxides (Barron & Singer 1945; Dixon & Needham 1946) . At first sight it may seem surprising th at an inhibitor such as phenylarsenoxide should owe its selective toxicity to inhibition of an enzyme system common to host and parasite, and several workers have fallen back upon the last line of defence-selective distribution.
Permeability and distribution theories are always difficult to prove and almost impossible to disprove and are therefore a favourite refuge from a difficult situation, but in this case a number of observations suggest th at there is no call for retreat to such a refuge. No doubt some of the differences between individual arsenoxides can be attributed to differences of distribution, but it seems improbable th at such widely different types of arsenical as arsenious acid, atoxyl and arsenophenylbutyric acid could all owe their ability to destroy trypanosomes selectively, in the presence of host cells, to a favourable distribution ratio. Moreover, if distribution were the key to the problem it would be most surprising th at no organic arsenical can be devised which will selectively destroy T.
Selective inhibition of an enzyme system of vital importance to the pathogen and less vitally important to the host seems to be the preferable explanation.
The arsenic sensitive group of trypanosomes have a high rate of cyanide-insensi tive glucose metabolism and are susceptible to selective destruction by arsenicals. Other trypanosomes differ from this group in th at their glucose metabolism is highly sensitive to inhibition by cyanide; they cannot be selectively destroyed in the presence of host cells by organic arsenicals (von Brand, Johnson & Rees 1946; von Brand & Tobie 1948) . Animals also possess a cyanide-sensitive respiratory system and can probably oxidize glucose in the presence of inhibitors of glycolysis by an alternative metabolic pathway involving phosphogluconic acid (Dickens 1938) .
It seems a reasonable assumption, then, th at organic arsenicals are effective in eliminating certain trypanosome infections because the trypanosomes concerned differ metabolically from the host cells in being entirely dependent upon a single mechanism of energy production, glycolysis, which is readily inhibited by arsenoxides. This view is supported by the observations of Marshall (1948) . T. evansi, an arsenic-sensitive trypanosome, is dependent for energy supply on the metabolism of glucose to pyruvate and is unable to utilize other common metabolites such as succinate, fumarate or amino-acids. In this respect it differs markedly from the host cells. Iodoacetate, a specific inhibitor of SH-enzymes, inhibits respiration of T. evansi to the extent of over 90 % at a concentration of m/4000 ; the same inhibitor at a concentration of m/3000 inhibits T. cruzi respiration only to the extent of 13 % (Marshall 1948; von Brand et al. 1946) . The metabolic pathways obviously differ in the two types of cell.
Detailed study of the mode of action of sulphonamides has indicated, as pointed out by Dr Woods at this meeting, th at these drugs also owe their selective toxicity to their ability to inhibit a metabolic reaction (formation of pteroylglutamic acid) which is essential to sulphonamide-sensitive organisms but not so essential to the host.
Penicillin is the most outstanding example of selective toxicity among chemo therapeutic drugs. I t is highly toxic to a large group of Gram-positive organisms and practically non-toxic to Gram-negative organisms or to animal cells. Gale & Taylor have pointed out th at Gram-positive organisms differ from Gram-negative in that they require a number of preformed amino-acids in their medium. Glutamic acid is synthesized readily by Gram-negative organisms and by animals, but has to be supplied in the medium of penicillin-sensitive Gram-positive organisms. It is transported across the cell wall of these organisms by an energy requiring metabolic reaction which is absent from Gram-negative micro-organisms (Gale & Taylor 1946 , 1947 Taylor 1947) . A strong case has been made out by Gale th at the selective toxicity of penicillin is due to inhibition of this metabolic transport reaction which is probably of no importance to the host cells (Gale & Rodwell 1948) .
Intensive study of three widely different types of drug has shown, therefore, that chemotherapeutic success is achieved in each case by inhibition of a metabolic reaction which is of vital importance to the parasite but of no particular importance to its host.
Comparative biochemistry has demonstrated many similarities between the metabolic pathways of lower organisms and animal cells. The glycolytic pathway is closely similar in muscle and some microbial cells and is mediated by the same co-enzymes. The tricarboxylic acid cycle is of importance in animal and in microbial cells; transamination is common to both; phosphorylative transfer of energy through adenosine triphosphate is common to both, and so on. We should not be surprised, therefore, when metabolite analogues of nicotinic acid, of thiamin, of riboflavin or of pyridoxal fail as chemotherapeutic remedies and cause metabolite deficiency in the host as well as in the invading organism. The anti-metabolite approach to chemotherapy demands a much fuller knowledge of the comparative biochemistry of host and pathogen than we yet possess.
Provided we admit our ignorance there is no harm in guessing at the type of metabolite analogue most likely to be chemotherapeutically useful. Indeed, until more is known of intermediary metabolism, particularly on the biosynthetic side, guesswork is essential to further progress.
In the search for metabolic reactions which are essential to pathogen but in essential to or of no importance in the host, there are two related fields which seem to merit attention, amino-acid metabolism and protein synthesis. I have already remarked on some differences in amino-acid metabolism between Gram-positive micro-organisms and their hosts; this difference might be exploited. At Hampstead we have synthesized some amino-acid analogues, but none of these have shown The failure is not wholly surprising; in addition to selective toxicity a drug must also possess some degree of biological stability. The majority of natural a-amino-acids undergo rapid oxidation in the animal body and their analogues probably undergo the same change. Stability can be conferred upon the amino-acid unit by combining it in peptide linkage with other amino-acids; metabolite analogues of such type offer a vast field for further exploration.
T a b le 5. A n t ib io t ic p e p t id e s a n tib io tic Two known facts make the peptide field particularly attractive, the peptide nature of several natural antibiotics and the species specificity of protein synthesis. Table 5 gives a list of some antibiotic peptides extracted from micro-organisms.
Sir Paul Fildes and others
The addition of licheniformin to this list has only become possible during recent weeks. Licheniformin is a mixture of several closely related antibiotic peptides (Callow & Work unpubl.) . The persistent occurrence of amino-acids of unnatural configuration in antibiotic peptides at first suggested that this might be the key to their antibiotic action. To test this hypothesis we made use of the analytical work of Consden, Gordon, Martin & Synge (1947) on gramicidin-S. The probable structure of gramicidin-S is a cyclic pentapeptide or a decapeptide with the following re curring sequence of amino-acids: ornithyl-leucyl-phenylalanyl-prolyl-valyl: As phenylalanine is the only amino-acid of the sequence with an unnatural (D) configuration (indicated in the above formula by a side chain below the backbone of the peptide chain), we thought at first th at we might achieve antibiotic action by synthesis of th at part of the peptide indicated by dotted lines. Two tripeptides L-leucyl-L-phenylalanyl-L-proline and L-leucyl-D-phenylalanyl-L-proline were syn thesized, but although both were slightly bacteriostatic there wT as no significant difference between the l -d -l and l -l -l peptides; extension of the chain to the pentapeptide stage also failed to produce antibiotic action (Harris & Work 1948) , and the conclusion was therefore reached that it was the structure of the molecule as a whole rather than the configuration of one particular amino-acid which was the key to the problem (Work 1948). The second point which lends attractiveness to the peptide field is, as already remarked, species specificity among proteins. Our search is for a metabolite analogue which will inhibit an enzymic system which is peculiar to pathogen and non-existent in its host. There is some evidence th at amino-acids of peculiar pattern unknown to animal protein may be utilized by micro-organisms for protein synthesis but this is not the point to which I wish to direct attention. Practically nothing is known of the mechanism of protein synthesis, but the end-result is a molecule which is completely specific for one particular species and sometimes even specific for subgroups within th at species. The mechanism for this synthesis must be equally species specific and open to selective inhibition by suitable metabolite analogues. A protein molecule contains several hundreds, or even thousands, of amino-acid residues representing about twenty different kinds of amino-acids; each kind of amino-acid is, therefore, repeated several times throughout the protein molecule to form an intricate pattern. Although the Bergmann-Niemann hypothesis of regularly recurring amino-acid residues has not found much support in its original form, it is reasonable to suppose that in protein synthesis the living cell will, for reasons of economy, use the same amino-acid sequence in the production of a number of proteins. I wish to suggest that amino-acid sequence may to some extent govern species specificity of proteins and th at a s uitable peptide with a favourable aminoacid sequence for one organism may be, for this reason, highly toxic to another group of organisms.
Some evidence can be cited in favour of this view; the growth requirements of micro-organisms are not invariably satisfied by a mixture of amino-acids, vitamins and salts; one of the additional factors required by Lactobacillus casei, designated strepogenin, is peptide in nature and is replaceable to some extent by the synthetic peptide seryl-glycyl-glutamic acid (Woolley 1946 (Woolley , 1948 . Since all three aminoacids are already present in the nutrient medium of Lb. casei it would appear th at this organism requires for optimum growth a peptide containing the sequence seryl-glycyl-glutamic acid, and is unable to synthesize this sequence sufficiently readily to permit rapid growth. On the basis of the Fildes-Woods hypothesis other related peptides might be expected to be growth inhibitory. Woolley found th at seryl-glycyl-aspartic acid was antibiotic for Lb. casei and th at it possessed the characteristic biological activity of a naturally occurring antibiotic, lycomarasmin, from Fusarium lycopersici (Plattner & Clauson-Kaas 1945) .
There are other suggestions in the literature also, th at some particular sequence of amino-acid residues may be of particular importance in the metabolism of higher animals; thus, tryptic digests of lactalbumin have a higher biological value in the dog than can be accounted for by their amino-acid composition (Bolling, Block & Chow 1947) ; certain animal proteins seem to be a rich source of strepogenin while egg-white, gelatin and salmine are devoid of strepogenin activity (Sprince & Woolley 1945) . Another small piece of evidence th at peptides with one particular aminoacid sequence may be characteristic of one species derives from the observation of Dent & Schilling (1948) that a dog digests a meal of dog protein without any rise in the amino-acid content of the portal blood, whereas, after any other protein meal, there is a sudden and clearly defined increase in free amino-acids in the blood; apparently the dog is able to utilize homologous protein without breaking it down first to its constituent amino-acids, but cannot do the same with heterologous protein.
There is one final point to which I should like to draw attention in connexion with selective toxicity and antibiotic action. Some of the most potent and highly selective of all naturally occurring antibiotics are the bacterial toxins. Ju st because their antibiotic action is directed against animals rather than against other micro organisms they are not generally classed as antibiotics but they nevertheless logically belong to this class of compounds. Crystalline botulinus toxin has been analyzed and found to contain fourteen amino-acids. No abnormality of amino-acid composition was found which would account for its extreme toxicity (Buehler, Bornor, Schantz & Lamanna 1946) . Diphtheria toxin is another highly selective antibiotic. Growth of Corynebacterium diphtheriae can be greatly slowed by reduction of the iron content of the medium, as the iron content is raised, increased growth is accompanied by increased production of toxin and of porphyrin.
Beyond a critical level of iron there is a rapid fall in yield of toxin and porphyrin but growth rate continues to increase. Simultaneously with the fall in porphyrin and toxin production the cytochrome spectrum of the cell becomes strong (Pappenheimer & Hendee 1947) . The suggestion has been made th at diphtheria toxin is a portion of the cytochrome molecule which the cell continues to produce in media containing concentrations of iron suboptimal for cytochrome production. The biological activity of the toxin could then be regarded as due to close resemblance to the protein portion of a vitally important animal enzyme system.
If I have seemed, in the latter half of my contribution to this symposium, to allow myself a generous amount of speculation, it is because, for the present, we lack exact knowledge of intermediary metabolism, knowledge which is a prerequisite for the intelligent application of the Fildes-Woods hypothesis to chemotherapy. If my speculations in the field of peptide chemistry do something to stimulate further study of natural and synthetic peptides they will not have been entirely worthless. Fildes, in 1940, put forward a plea for 'A rational approach to research in chemo therapy ' in which he advocated research directed towards the preparation of modi fied essential metabolites which should be sufficiently closely related to the essential metabolite on which they were based as to fit the same enzyme, but sufficiently dissimilar as to be themselves devoid of essential metabolic activity. This idea was taken up widely, and fruitfully, but often without due regard to the factors making for true similarity between metabolite and inhibitor; the present paper is an appeal for such a rational approach to chemotherapy to be based on a proper appreciation of the structural factors on which such similarity must be founded.
It must be admitted th at most of the metabolite analogues which have been prepared and tested as a result of the general acceptance of Fildes's idea have proved of little value as practical chemotherapeutic agents. A possible reason for this lack of success lies in the fact th at the analogies between metabolite and inhibitor have been purely 'pictorial' in nature; in general, the inhibitors have simply been made to 'look like' the metabolite. In the author's opinion, Fildes's principle is unlikely to be very fruitful if we continue to confine ourselves to such naive pictorial analogies which are both not enough and too much. Pictorial analogy is not enough because an analogue may look like a metabolite and yet lack the chemical groupings necessary for combination with the appropriate enzyme; it leads us to overemphasize the geometry and underemphasize the chemistry of the molecule. Pictorial analogy is too much, since there may be a great deal in the structure of the metabolite which is not directly concerned in its attachment to the enzyme; it leads us to overload our inhibitors with possibly unnecessary complica tions. In order to model inhibitors more rationally on essential metabolites we must
